ReviewMolecular cancer2023

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.

Christian Sordo-Bahamonde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.